Table of Contents Author Guidelines Submit a Manuscript
Anesthesiology Research and Practice
Volume 2012 (2012), Article ID 930487, 5 pages
http://dx.doi.org/10.1155/2012/930487
Clinical Study

The Influence of Pharmacological Preconditioning with Sevoflurane on Incidence of Early Allograft Dysfunction in Liver Transplant Recipients

1Department of Anesthesiology and Critical Care, Republican Center of Organ and Tissue Transplantation, Semashko Street 8, 220116 Minsk, Belarus
2Department of Transplantology, Republican Center of Organ and Tissue Transplantation, Semashko Street 8, 220116 Minsk, Belarus

Received 15 June 2012; Accepted 2 July 2012

Academic Editor: Gebhard Wagener

Copyright © 2012 Andrei F. Minou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “HHS/HRSA/HSB/DOT OPTN / SRTR,” Annual Data Report, pp. 54–58, 2010.
  2. N. R. Barshes, I. B. Horwitz, L. Franzini, J. M. Vierling, and J. A. Goss, “Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers,” American Journal of Transplantation, vol. 7, no. 5, pp. 1265–1270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Alkofer, B. Samstein, J. V. Guarrera et al., “Extended-donor criteria liver allografts,” Seminars in Liver Disease, vol. 26, no. 3, pp. 221–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Beck-Schimmer, S. Breitenstein, S. Urech et al., “A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic,” Annals of Surgery, vol. 248, no. 6, pp. 909–916, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. C. Song, Y. M. Sun, L. Q. Yang, M. Z. Zhang, Z. J. Lu, and W. F. Yu, “A comparison of liver function after hepatectomy with inflow occlusion between sevoflurane and propofol anesthesia,” Anesthesia and Analgesia, vol. 111, no. 4, pp. 1036–1041, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. K. M. Olthoff, L. Kulik, B. Samstein et al., “Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors,” Liver Transplantation, vol. 16, no. 8, pp. 943–949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Feng, N. P. Goodrich, J. L. Bragg-Gresham et al., “Characteristics associated with liver graft failure: the concept of a donor risk index,” American Journal of Transplantation, vol. 6, no. 4, pp. 783–790, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. J. Blok, A. E. Braat, R. Adam et al., “Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region,” Liver Transplantation, vol. 18, no. 1, pp. 113–120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Kotsch, F. Ulrich, A. Reutzel-Selke et al., “Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation a prospective randomized controlled trial,” Annals of Surgery, vol. 248, no. 6, pp. 1042–1049, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. S. Baskin-Bey, K. Washburn, S. Feng et al., “Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury,” American Journal of Transplantation, vol. 7, no. 1, pp. 218–225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Bogetti, H. N. Sankary, T. M. Jarzembowski et al., “Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury,” Clinical Transplantation, vol. 19, no. 4, pp. 507–511, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. D. S. Peter, D. J. Post, M. I. Rodriguez-Davalos, D. D. Douglas, A. A. Moss, and D. C. Mulligan, “Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation,” Liver Transplantation, vol. 9, no. 2, pp. 144–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. J. D. Lang, X. Teng, P. Chumley et al., “Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation,” Journal of Clinical Investigation, vol. 117, no. 9, pp. 2583–2591, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. W. Busuttil, G. S. Lipshutz, J. W. Kupiec-Weglinski et al., “RPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study,” American Journal of Transplantation, vol. 11, no. 4, pp. 786–797, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Imai, S. Kon, and H. Inaba, “Effects of halothane, isoflurane and sevoflurane on ischemia-reperfusion injury in the perfused liver of fasted rats,” Acta Anaesthesiologica Scandinavica, vol. 40, no. 10, pp. 1242–1248, 1996. View at Google Scholar · View at Scopus
  16. H. Ishida, Y. Kadota, T. Sameshima, A. Nishiyama, T. Oda, and Y. Kanmura, “Comparison between sevoflurane and isoflurane anesthesia in pig hepatic ischemia-reperfusion injury,” Journal of Anesthesia, vol. 16, no. 1, pp. 44–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Bedirli, E. Ofluoglu, M. Kerem et al., “Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model,” Anesthesia and Analgesia, vol. 106, no. 3, pp. 830–837, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. S. Ko, M. S. Gwak, S. J. Choi et al., “The effects of desflurane and sevoflurane on hepatic and renal functions after right hepatectomy in living donors,” Transplant International, vol. 23, no. 7, pp. 736–744, 2010. View at Publisher · View at Google Scholar · View at Scopus